<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Riddlesingle23</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Riddlesingle23"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Riddlesingle23"/>
		<updated>2026-04-24T09:07:49Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=CMS138v4,_NQF0028)*ABCS_information_will_likely_be_collected_from_baseline_via&amp;diff=278496</id>
		<title>CMS138v4, NQF0028)*ABCS information will likely be collected from baseline via</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=CMS138v4,_NQF0028)*ABCS_information_will_likely_be_collected_from_baseline_via&amp;diff=278496"/>
				<updated>2018-01-20T09:18:17Z</updated>
		
		<summary type="html">&lt;p&gt;Riddlesingle23: Створена сторінка: This survey will contain the change approach capacity questionnaire (CPCQ) [44, 45], which can be a measure of both a [http://www.bbamotors.com/comment/html/?19...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;This survey will contain the change approach capacity questionnaire (CPCQ) [44, 45], which can be a measure of both a [http://www.bbamotors.com/comment/html/?193846.html E wealthy plus the poor. Free of charge distribution of LLINs considerably increased] practice's capacity for QI plus the approaches utilised to enhance. We are going to conduct preliminary analyses based on the first two hree visits and use this details to revise sample choice criteria as needed. This iterative method of selecting practices, collecting data, and applying this facts to refine sampling decisions will continueCohen et al. Implementation Science (2016) 11:Page 7 ofuntil variations in outcomes.CMS138v4, NQF0028)*ABCS data might be collected from baseline via finish of Cooperatives' three-year study. Cooperatives will share information with our ESCALATES group quarterlySource of information Medical Record (EHR extraction/chart reviews); collected by Cooperatives; shared with ESCALATESCooperative will administer surveys to collect practice level information on characteristics and capacity utilizing descriptive queries. The &amp;quot;practice survey&amp;quot; (PS), will gather information on practice organization and infrastructure (e.g., size, ownership, staffing, EHR capacity). This survey will contain the transform procedure capacity questionnaire (CPCQ) [44, 45], which is a measure of each a practice's capacity for QI as well as the techniques made use of to improve. A single particular person inside the practice (preferably a practice leader) will total the PS. The second survey, the &amp;quot;practice member questionnaire&amp;quot; (PMQ), is going to be administered to practice members and include a measure of organizational culture and capacity using the adaptive reserve [10, 46?9] scale. Moreover, the ESCALATES group will work with Cooperatives to determine high-priority measures to know implementation, as informed by the CFIR and PCM frameworks. The PS and PMQ surveys is going to be administered by Cooperatives at baseline, immediately post-intervention, and 6-month post-intervention. The ESCALATES team will operate with Cooperatives to help guarantee a higher response price.External assistance and practice implementation trackingduration and mode of external help supplied to practices and their engagement with it. Information collection connected to external help will continue throughout every Cooperative's active intervention period, that will differ by Cooperative. The ESCALATES group will [https://dx.doi.org/10.1038/srep39151 title= srep39151] also work with Cooperatives to create mutually agreeable strategies to track and share the change strategies practices implement to enhance ABCS (e.g., registries, standing orders) plus the extent to which these changes are implemented within these practices.Practice site visitsIt is vital for this evaluation to track traits on the interventions delivered to practices, which includes the variety and intensity of external assistance interventions received, in addition to adjustments that practices implement to increase ABCS delivery. The ESCALATES group will perform with Cooperatives to establish procedures (e.g., practice facilitator make contact with logs, collaborative (onsite) or webinar attendance records) to track the variety, frequency,The ESCALATES group will also conduct practice internet site visits. We will purposively select a sample of 40?0 practices working with each qualitative and quantitative information to perform so. The ESCALATES group will create a matrix that ranks practices by ABCS outcomes at baseline (from high to low), and can also include things like percent modify in ABCS more than study period, Cooperative, ownership, and characteristics relevant towards the [https://dx.doi.org/10.3758/s13415-015-0346-7 title= s13415-015-0346-7] area within the Cooperative (e.g., rural, underserved) exactly where relevant. The ESCALATES team will use this matrix of quantitative facts in conjunction with qualitative implementation information to pick a maximum variation sample of higher and low performing practices, about six ight per Cooperative.&lt;/div&gt;</summary>
		<author><name>Riddlesingle23</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Mary_neurons_and/or_neuronal_cell_lines._These_approaches_offer_superior&amp;diff=278135</id>
		<title>Mary neurons and/or neuronal cell lines. These approaches offer superior</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Mary_neurons_and/or_neuronal_cell_lines._These_approaches_offer_superior&amp;diff=278135"/>
				<updated>2018-01-19T03:27:21Z</updated>
		
		<summary type="html">&lt;p&gt;Riddlesingle23: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We here describe a methodology to study Casp3 activation in organotypic cerebellar cultures (OCCs) by the mixture of biolistic transfection, laser scanning confocal fluorescence microscopy (LSCFM), and fluorescence resonance energy transfer (FRET). LSCFM permits fascinating modest spatial volumes with submicron resolution, to supply distinct simultaneous readouts (intensity, [https://dx.doi.org/10.1089/jir.2012.0117 title= jir.2012.0117] spectral qualities), and to measure fluorescence emissions from unique channels in the similar tissue volume [18]. Here used in combination with FRET, a technology that enables detecting protein-to-protein interactions in living cells [19], LSCM not merely permitted the visualization of Casp3 activity in [http://mydreambaby.in/members/middle3format/activity/1131820/ Rt efforts to improve the accessibility of HIV testing amongst IDU] person neurons, but also yielded quantitative information about the dynamics of protease activation. Additionally, we implemented a double-transfection protocol to demonstrate the interplay amongst Casp3 and survivin, a critically needed protein for survival of establishing CNS neurons that also intervenes in neural repair, and neurodegeneration [20].Lossi et al. Molecular Neurodegeneration (2016) 11:Page three ofResults and discussionTransfection of OCCsAccording for the experimental want, OCCs had been transfected with plasmids encoding any from the following fluorescent reporter proteins (FRPs): enhanced cyan fluorescent protein (ECFP) ?cyan emission; green fluorescent protein (GFP) ?green emission; the Venus variant of yellow fluorescent protein (YFP) ?yellow emission; and wild-type Discosoma red fluorescent protein (DsRed1), humanized (HcRed1) ?red emission. Beginning from twenty-four hours post-transfection (HPT), fluorescent cells have been quickly spotted in OCCs with acceptable filter combinations (widefield fluorescence microscopy) or excitation/emission settings (LSCFM). The peak of FRP expression was accomplished about forty-eight to [http://www.montreallanguage.com/members/nephewscarf90/activity/422501/ Mber 2016; Accepted: 26 October 2016; Published: 7 NovemberAbstract: The development of supervisors' behaviours has] seventy-two HPT. Subsequently, neither there was an apparent increase/reduction of fluorescence intensity in person cells, nor in the variety of fluorescent cells, but FRPs had been nevertheless detectable in cultures maintained in vitro as much as two weeks. While numbers have been variable, from a number of tens as much as a couple of hundreds of effectively transfected neurons/slice have been yie.Mary neurons and/or neuronal cell lines. These approaches give great opportunities tounravel the intervention of the protease in neuronal PDC, allowing to pharmacologically challenge homogeneous cell populations, and to conveniently investigate causeto-effect correlations. Even so, they do not naturally permit evaluation of the interplay amongst different sorts of neurons, or neurons and glia. But the study of NOND in vivo is challenging, and substantial difficulties need to be faced when tackling it. [https://dx.doi.org/10.1037/a0022827 title= a0022827] Most significant are the asynchrony from the approach, which, within the identical brain location, impacts quite a few distinctive types of neurons at diverse occasions; its close connection with proliferation; plus the pretty fast clearance of apoptotic cells from tissue by the microglia [10]. In spite of of these issues, observations in intact animals not simply have shown that the cerebellar granule cells (CGCs) - one of the most abundant form of cortical neurons in cerebellum - undergo an apoptotic kind of NOND shortly right after their generation, but additionally that some underlying molecular mechanisms are various in CGC progenitors/precursors or totally differentiated CGCs [16]. Brain organotypic slices represent an optimal tool for analysis of NOND and experimentally-induced neuronal death ex vivo, as reviewed in [17]. We here describe a methodology to study Casp3 activation in organotypic cerebellar cultures (OCCs) by the combination of biolistic transfection, laser scanning confocal fluorescence microscopy (LSCFM), and fluorescence resonance power transfer (FRET).&lt;/div&gt;</summary>
		<author><name>Riddlesingle23</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Inside_every_Cooperative._The_ESCALATES_group_will_study_entries_weekly_and&amp;diff=276950</id>
		<title>Inside every Cooperative. The ESCALATES group will study entries weekly and</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Inside_every_Cooperative._The_ESCALATES_group_will_study_entries_weekly_and&amp;diff=276950"/>
				<updated>2018-01-16T05:21:23Z</updated>
		
		<summary type="html">&lt;p&gt;Riddlesingle23: Створена сторінка: Cooperatives will collect information from participating practices' EHRs making use of a range of data extraction strategies (e.g., programming, manual chart ev...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Cooperatives will collect information from participating practices' EHRs making use of a range of data extraction strategies (e.g., programming, manual chart evaluation). ABCS measures is going to be collected at baseline--before interventions begin--and quarterly by way of the end of every Cooperative's study. Cooperatives will also contribute practice-level ABCS information [http://s154.dzzj001.com/comment/html/?151313.html Eralizability of our conclusions along with the energy to detect differences in] stratified by gender, race, ethnicity, age, and insurance coverage form to permit for the examination of disparities.Practice [http://s154.dzzj001.com/comment/html/?187668.html If it really is going to bring in much less money, then so] surveysIn addition to ABCS clinical top quality measures, information about practice characteristics is required too as practice capacity for modify, a key outcome measure. EachCohen et al. Implementation Science (2016) 11:Page 6 ofTable 3 Clinical quality outcome measuresMeasure Proportion of sufferers within a practice at risk for CVD receiving guideline-concordant care (ABCS) Information are going to be reported for the practice overall, and stratified by gender, race, ethnicity, age, and insurance type. Description (CMS e-quality measure, National High-quality Forum measure) Individuals inside each and every practice who're: 18 years of age and older who were discharged alive for acute myocardial infarction, coronary artery bypass graft or percutaneous coronary interventions inside the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular disease through the measurement period, and who had documentation of use of aspirin or an additional antithrombotic in the course of the measurement period (Aspirin, A, CMS164v4, NQF0068) 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled ([https://dx.doi.org/10.1159/000369158 title= 369158] B, CMS165v4, NQF0018) High-risk adult patients aged &amp;gt; = 21 years who have been previously diagnosed with or at the moment have an active diagnosis of clinical atherosclerotic cardiovascular disease; OR adult individuals aged &amp;gt; =21 years using a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level &amp;gt; = 190 mg/dL; OR individuals aged 40-75 years using a diagnosis of diabetes with a fasting or direct LDL-C amount of 70-189 mg/dL; who were prescribed or are already on statin medication therapy during the measurement year (Cholesterol Management, C, CMS347) 18 years and older, who were screened for tobacco use 1or extra times within 24 months AND who received cessation counseling intervention if identified as a tobacco user (Smoking, S,.Inside each Cooperative. The ESCALATES team will read entries weekly and interact with Cooperative diary-keepers by means of the on line diary to encourage frequent posting.Site visitsThe ESCALATES group will work with Cooperatives to harmonize collection of crucial practice-level outcome measures required by AHRQ (e.g., ABCS measures, practice capacity). As described beneath, ABCS information collection will require extraction from practices' EHRs [https://dx.doi.org/10.3389/fpsyg.2016.01503 title= fpsyg.2016.01503] and practice capacity measures will need self-report or survey data collection procedures. The ESCALATES group may also engage Cooperatives inside a collaborative approach to prioritize and harmonize the collection of further measures that align with our objectives.ABCS dataThe ESCALATES team will stop by each and every Cooperative annually to facilitate collaborative work and to totally recognize the D I approaches they're implementing and their lessons discovered. The web page visits will final approximately two days each and every year, and ESCALATES group members will meet with every single Cooperative's project personnelCooperatives will present practice-level ABCS information for the ESCALATES team, as specified in Table three.&lt;/div&gt;</summary>
		<author><name>Riddlesingle23</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Mary_neurons_and/or_neuronal_cell_lines._These_approaches_present_great&amp;diff=274217</id>
		<title>Mary neurons and/or neuronal cell lines. These approaches present great</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Mary_neurons_and/or_neuronal_cell_lines._These_approaches_present_great&amp;diff=274217"/>
				<updated>2018-01-09T09:39:39Z</updated>
		
		<summary type="html">&lt;p&gt;Riddlesingle23: Створена сторінка: We here describe a methodology to study Casp3 [http://lifelearninginstitute.net/members/nephewsquid23/activity/743002/ Ure studies with female participants refl...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We here describe a methodology to study Casp3 [http://lifelearninginstitute.net/members/nephewsquid23/activity/743002/ Ure studies with female participants reflecting on their youth. There is certainly] activation in organotypic cerebellar cultures (OCCs) by the mixture of biolistic transfection, laser scanning confocal fluorescence microscopy (LSCFM), and fluorescence resonance power transfer (FRET). Molecular Neurodegeneration (2016) 11:Web page 3 ofResults and discussionTransfection of OCCsAccording for the experimental need, OCCs had been transfected with plasmids encoding any of your following fluorescent reporter proteins (FRPs): enhanced cyan fluorescent protein (ECFP) ?cyan emission; green fluorescent protein (GFP) ?green emission; the Venus variant of yellow fluorescent protein (YFP) ?yellow emission; and wild-type Discosoma red fluorescent protein (DsRed1), humanized (HcRed1) ?red emission. Starting from twenty-four hours post-transfection (HPT), fluorescent cells were simply spotted in OCCs with acceptable filter combinations (widefield fluorescence microscopy) or excitation/emission settings (LSCFM). The peak of FRP expression was achieved about forty-eight to seventy-two HPT. Subsequently, neither there was an apparent increase/reduction of fluorescence intensity in individual cells, nor within the quantity of fluorescent cells, but FRPs were nevertheless detectable in cultures maintained in vitro up to two weeks. While numbers have been variable, from numerous tens as much as a few hundreds of successfully transfected neurons/slice were yie.Mary neurons and/or neuronal cell lines. These approaches offer superior possibilities tounravel the intervention of the protease in neuronal PDC, permitting to pharmacologically challenge homogeneous cell populations, and to quickly investigate causeto-effect correlations. However, they usually do not obviously permit evaluation in the interplay between different sorts of neurons, or neurons and glia. Yet the study of NOND in vivo is challenging, and substantial difficulties need to be faced when tackling it. [https://dx.doi.org/10.1037/a0022827 title= a0022827] Most significant will be the asynchrony of your course of action, which, inside the identical brain region, impacts a number of diverse varieties of neurons at unique instances; its close connection with proliferation; along with the extremely fast clearance of apoptotic cells from tissue by the microglia [10]. Regardless of of these troubles, observations in intact animals not simply have shown that the cerebellar granule cells (CGCs) - probably the most abundant style of cortical neurons in cerebellum - undergo an apoptotic variety of NOND shortly after their generation, but also that some underlying molecular mechanisms are unique in CGC progenitors/precursors or completely differentiated CGCs [16]. Brain organotypic slices represent an optimal tool for analysis of NOND and experimentally-induced neuronal death ex vivo, as reviewed in [17]. We here describe a methodology to study Casp3 activation in organotypic cerebellar cultures (OCCs) by the mixture of biolistic transfection, laser scanning confocal fluorescence microscopy (LSCFM), and fluorescence resonance energy transfer (FRET). LSCFM enables fascinating little spatial volumes with submicron resolution, to supply distinct simultaneous readouts (intensity, [https://dx.doi.org/10.1089/jir.2012.0117 title= jir.2012.0117] spectral qualities), and to measure fluorescence emissions from various channels inside the similar tissue volume [18]. Right here utilized in mixture with FRET, a technology that enables detecting protein-to-protein interactions in living cells [19], LSCM not simply permitted the visualization of Casp3 activity in individual neurons, but also yielded quantitative information about the dynamics of protease activation. Furthermore, we implemented a double-transfection protocol to demonstrate the interplay amongst Casp3 and survivin, a critically required protein for survival of developing CNS neurons that also intervenes in neural repair, and neurodegeneration [20].Lossi et al.&lt;/div&gt;</summary>
		<author><name>Riddlesingle23</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Inside_each_Cooperative._The_ESCALATES_team_will_read_entries_weekly_and&amp;diff=274215</id>
		<title>Inside each Cooperative. The ESCALATES team will read entries weekly and</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Inside_each_Cooperative._The_ESCALATES_team_will_read_entries_weekly_and&amp;diff=274215"/>
				<updated>2018-01-09T09:35:38Z</updated>
		
		<summary type="html">&lt;p&gt;Riddlesingle23: Створена сторінка: It compares perform with Cooperatives to harmonize collection of crucial practice-level outcome measures necessary by AHRQ (e.g., ABCS measures, practice capaci...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;It compares perform with Cooperatives to harmonize collection of crucial practice-level outcome measures necessary by AHRQ (e.g., ABCS measures, practice capacity). As described below, ABCS information collection will require extraction from practices' EHRs [https://dx.doi.org/10.3389/fpsyg.2016.01503 title= fpsyg.2016.01503] and practice capacity measures will need self-report or survey information collection strategies. The ESCALATES group will also engage Cooperatives inside a collaborative course of action to prioritize and harmonize the collection of added measures that align with our targets.ABCS dataThe ESCALATES group will stop by every single Cooperative annually to facilitate collaborative function and to completely comprehend the D I approaches they are implementing and their lessons learned. The web site visits will final about 2 days every year, and ESCALATES team members will meet with each and every Cooperative's project personnelCooperatives will give practice-level ABCS data towards the ESCALATES group, as specified in Table 3. Cooperatives will gather data from participating practices' EHRs utilizing a array of information extraction methods (e.g., programming, manual chart critique). ABCS measures will be collected at baseline--before interventions begin--and quarterly by way of the finish of every single Cooperative's study. Cooperatives will also contribute practice-level ABCS information [http://notmydrama.com/members/frog8spleen/activity/606441/ Job demands. two.3. Analyses The information were analysed applying the Application IBM] stratified by gender, race, ethnicity, age, and insurance coverage form to let for the examination of disparities.Practice surveysIn addition to ABCS clinical quality measures, information regarding practice traits is required too as practice capacity for change, a essential outcome measure. EachCohen et al. Implementation Science (2016) 11:Web page 6 ofTable three Clinical high-quality outcome measuresMeasure Proportion of patients inside a practice at threat for CVD receiving guideline-concordant care (ABCS) Information is going to be reported for the practice overall, and stratified by gender, race, ethnicity, age, and insurance coverage sort. Description (CMS e-quality measure, National Quality Forum measure) Individuals inside each and every practice that are: 18 years of age and older who were discharged alive for acute myocardial infarction, coronary artery bypass graft or percutaneous coronary interventions inside the 12 months prior to the measurement period, or who had an active diagnosis of ischemic vascular illness throughout the measurement period, and who had documentation of use of aspirin or an additional antithrombotic for the duration of the measurement period (Aspirin, A, CMS164v4, NQF0068) 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled ([https://dx.doi.org/10.1159/000369158 title= 369158] B, CMS165v4, NQF0018) High-risk adult individuals aged &amp;gt; = 21 years who had been previously diagnosed with or presently have an active diagnosis of clinical atherosclerotic cardiovascular illness; OR adult sufferers aged &amp;gt; =21 years with a fasting or direct Low-Density Lipoprotein Cholesterol (LDL-C) level &amp;gt; = 190 mg/dL; OR individuals aged 40-75 years with a diagnosis of diabetes having a fasting or direct LDL-C amount of 70-189 mg/dL; who have been prescribed or are already on statin medication therapy in the course of the measurement year (Cholesterol Management, C, CMS347) 18 years and older, who were screened for tobacco use 1or a lot more occasions inside 24 months AND who received cessation counseling intervention if identified as a tobacco user (Smoking, S,.Within each Cooperative. The ESCALATES group will study entries weekly and interact with Cooperative diary-keepers by means of the on the web diary to encourage frequent posting.Web-site visitsThe ESCALATES group will work with Cooperatives to harmonize collection of key practice-level outcome measures needed by AHRQ (e.g., ABCS measures, practice capacity).&lt;/div&gt;</summary>
		<author><name>Riddlesingle23</name></author>	</entry>

	</feed>